<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02618499</url>
  </required_header>
  <id_info>
    <org_study_id>Funda05</org_study_id>
    <nct_id>NCT02618499</nct_id>
  </id_info>
  <brief_title>Delayed Cord Clamping and Use of Oxytocin</brief_title>
  <official_title>Is Placental Transfusion Influenced by the Early Administration of Oxytocin?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundacion para la Salud Materno Infantil</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fundacion para la Salud Materno Infantil</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if oxytocin administration immediately after
      delivery of the infant modifies the volume of placental transfusion in healthy term infants.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Randomized controlled trial with 2 arms to test the influence of oxytocin in placental
      transfusion.

      Placental transfusion: the amount of blood that passes to the baby from the time of birth
      until the cord is clamped.

      The difference in weight between a measurement at birth and a second one after clamping the
      cord at 3 minutes will be considered as proxy for placental transfusion.

      In one arm the oxytocin will be used immediately after birth and the cord clamped at 3
      minutes In the other arm the oxytocin will be administered at 3 minutes of birth after the
      cord is clamped.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Futility suggested by DSMC
  </why_stopped>
  <start_date>May 2016</start_date>
  <completion_date type="Actual">November 2016</completion_date>
  <primary_completion_date type="Actual">November 2016</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>placental transfusion</measure>
    <time_frame>between birth and 3 minutes of life</time_frame>
    <description>Difference in body weight between birth and 3 minutes of life</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>bilirubin</measure>
    <time_frame>at 36/48 hours</time_frame>
    <description>Bilirubin level</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hematocrit</measure>
    <time_frame>at 36/48 hours</time_frame>
    <description>Hematocrit levels</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maternal blood loss</measure>
    <time_frame>after birth for 30 minutes</time_frame>
    <description>measure of the blood loss</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">180</enrollment>
  <condition>Placental Transfusion</condition>
  <arm_group>
    <arm_group_label>oxytocin inmediately at birth</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intervention: Timing of administration of postpartum Oxytocin. 10 international Units (IU) immediately at birth will be given intravenously (IV) to the mother.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>oxytocin at 3 minutes</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intervention: Timing of administration of postpartum Oxytocin. 10 IU IV at 3 minutes immediately after the cord is clamped</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Timing of administration of post partum Oxytocin</intervention_name>
    <description>10 IU of oxytocin given IV at different times after birth</description>
    <arm_group_label>oxytocin inmediately at birth</arm_group_label>
    <arm_group_label>oxytocin at 3 minutes</arm_group_label>
    <other_name>syntosinon</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy single Term pregnancies.

          -  Vaginal delivery.

          -  Informed consent obtained.

          -  Presence of an investigator

        Exclusion Criteria:

          -  Placenta previa.

          -  Previous history of Postpartum hemorrhage

          -  Intrauterine growth restriction .

          -  Major congenital malformations.

          -  Eclampsia

          -  Extraction of blood sample for bank of umbilical cord stem cells.

        Elimination criteria:

          -  Need for immediate assistance of the newborn

          -  Birth weight less than 2500 g

          -  Nuchal cord wrapped too tight

          -  Surgically finished delivery

          -  Short umbilical cord which might prevent placing the infant on the scale

          -  Technical difficulties to obtain the weight
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nestor Vain, MD</last_name>
    <role>Study Director</role>
    <affiliation>Fundasamin</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Daniela S Satragno, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fundasamin</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Instituto de Ginecologia y Maternidad Nuestra Se√±ora de la Merced</name>
      <address>
        <city>San Miguel de Tucuman</city>
        <state>Tucuman</state>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Argentina</country>
  </location_countries>
  <link>
    <url>http://apps.who.int/rhl/evidence_summaries/beneficial/es/index.html</url>
    <description>WHO recommendations</description>
  </link>
  <reference>
    <citation>McDonald SJ, Middleton P, Dowswell T, Morris PS. Effect of timing of umbilical cord clamping of term infants on maternal and neonatal outcomes. Cochrane Database Syst Rev. 2013 Jul 11;(7):CD004074. doi: 10.1002/14651858.CD004074.pub3. Review.</citation>
    <PMID>23843134</PMID>
  </reference>
  <reference>
    <citation>Vain NE, Satragno DS, Gorenstein AN, Gordillo JE, Berazategui JP, Alda MG, Prudent LM. Effect of gravity on volume of placental transfusion: a multicentre, randomised, non-inferiority trial. Lancet. 2014 Jul 19;384(9939):235-40. doi: 10.1016/S0140-6736(14)60197-5. Epub 2014 Apr 17.</citation>
    <PMID>24746755</PMID>
  </reference>
  <reference>
    <citation>Westhoff G, Cotter AM, Tolosa JE. Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage. Cochrane Database Syst Rev. 2013 Oct 30;(10):CD001808. doi: 10.1002/14651858.CD001808.pub2. Review.</citation>
    <PMID>24173606</PMID>
  </reference>
  <reference>
    <citation>Lalonde A; International Federation of Gynecology and Obstetrics. Prevention and treatment of postpartum hemorrhage in low-resource settings. Int J Gynaecol Obstet. 2012 May;117(2):108-18. doi: 10.1016/j.ijgo.2012.03.001.</citation>
    <PMID>22502595</PMID>
  </reference>
  <reference>
    <citation>Soltani H, Hutchon DR, Poulose TA. Timing of prophylactic uterotonics for the third stage of labour after vaginal birth. Cochrane Database Syst Rev. 2010 Aug 4;(8):CD006173. doi: 10.1002/14651858.CD006173.pub2. Review.</citation>
    <PMID>20687079</PMID>
  </reference>
  <reference>
    <citation>Begley CM, Gyte GM, Devane D, McGuire W, Weeks A. Active versus expectant management for women in the third stage of labour. Cochrane Database Syst Rev. 2015 Mar 2;(3):CD007412. doi: 10.1002/14651858.CD007412.pub4. Review.</citation>
    <PMID>25730178</PMID>
  </reference>
  <reference>
    <citation>Yao AC, Hirvensalo M, Lind J. Placental transfusion-rate and uterine contraction. Lancet. 1968 Feb 24;1(7539):380-3.</citation>
    <PMID>4169972</PMID>
  </reference>
  <reference>
    <citation>Farrar D, Airey R, Law GR, Tuffnell D, Cattle B, Duley L. Measuring placental transfusion for term births: weighing babies with cord intact. BJOG. 2011 Jan;118(1):70-5. doi: 10.1111/j.1471-0528.2010.02781.x. Epub 2010 Nov 18.</citation>
    <PMID>21083868</PMID>
  </reference>
  <reference>
    <citation>Trudnowski RJ, Rico RC. Specific gravity of blood and plasma at 4 and 37 degrees C. Clin Chem. 1974 May;20(5):615-6.</citation>
    <PMID>4826961</PMID>
  </reference>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 10, 2015</study_first_submitted>
  <study_first_submitted_qc>November 27, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 1, 2015</study_first_posted>
  <last_update_submitted>November 22, 2016</last_update_submitted>
  <last_update_submitted_qc>November 22, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 23, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>birth</keyword>
  <keyword>oxytocin</keyword>
  <keyword>placental transfusion</keyword>
  <keyword>umbilical cord clamping</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Oxytocin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

